Tara C. Mitchell, MD, discusses considerations and lingering questions regarding pre- and post-operative management strategies in stage IIB/IIIC melanoma.
Melanoma News
Melanoma Patients’ Given New Hope With Ground-Breaking Clinical Trial | 10 News First
Melanoma patients with some of the worst diagnoses having seen the disease spread to their brains are tonight being given a major boost of hope, all thanks to a ground-breaking clinical trial.
New data confirms melanoma treatment having life-saving impacts | ABC NEWS
ABC News provides around the clock coverage of news events as they break in Australia and abroad. It’s news when you want it, from Australia’s most trusted news organisation.
Updated NCCN Guidelines Recommend HEPZATO KIT for Hepatic-Dominant Uveal Melanoma
The NCCN Guidelines for metastatic uveal melanoma now recommend HEPZATO KIT as a Category 2A treatment option for patients with hepatic-dominant disease.